Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mohty

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Journal of Internal Medicine|October 30, 2018
Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysisJ Canaani, E Beohou, M Labopin, et al.
Bone Marrow Transplantation|November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysisT Ruutu, A Gratwohl, D Niederwieser, et al.
Leukemia|June 16, 2012
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantationF Baron, M Labopin, D Niederwieser, et al.
Bone Marrow Transplantation|July 5, 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costsC Faucher, A G Le Corroller Soriano, B Esterni, et al.
Bone Marrow Transplantation|January 15, 2014
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationF Baron, M Labopin, D Blaise, et al.
Bone Marrow Transplantation|November 9, 2004
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)M Mohty, M Attal, G Marit, et al.
Bone Marrow Transplantation|November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|April 19, 2016
Autologous transplant remains the preferred therapy for relapsed APL in CR2C Ganzel, V Mathews, K Alimoghaddam, et al.
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Journal of Internal Medicine|October 30, 2018
Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysisJ Canaani, E Beohou, M Labopin, et al.
Bone Marrow Transplantation|November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysisT Ruutu, A Gratwohl, D Niederwieser, et al.
Leukemia|June 16, 2012
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantationF Baron, M Labopin, D Niederwieser, et al.
Bone Marrow Transplantation|July 5, 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costsC Faucher, A G Le Corroller Soriano, B Esterni, et al.
Bone Marrow Transplantation|January 15, 2014
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationF Baron, M Labopin, D Blaise, et al.
Bone Marrow Transplantation|November 9, 2004
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)M Mohty, M Attal, G Marit, et al.
Bone Marrow Transplantation|November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|April 19, 2016
Autologous transplant remains the preferred therapy for relapsed APL in CR2C Ganzel, V Mathews, K Alimoghaddam, et al.
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
Pageof 18